MedTrace Logo

Impact of Neuropathic Post-Zosterian Pain on the Cognition

NCT00989040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-01-30

No results posted yet for this study

Summary

Pain is defined as a sensorial and emotional phenomenon and lead consequences on the cognition. These consequences could be increased with usual treatment. So the aim of this study is to explore these cognitive consequences.

Conditions

  • Neuropathic Post-zosterian Pain
  • Cognition

Interventions

DRUG

usual treatment: Versatis

* To explore if the cognition is failed in treated patients suffering of neuropathic postzosteria pain. * To see if treated patients with patch (Versatis®) have better cognition than treated patients without patch.

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Claude Dubray, PUPH · CIC-CPC Clermont-Ferrand

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-06-30
Completion
2009-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00989040 on ClinicalTrials.gov